New GLP-1 and multi-agonist medications are entering the market, potentially reducing supply pressure on existing drugs
Claudia von Boeselager (23:04) And would you say the microplastics, the endocrine disruptors, the phthalates, all the different things as you drink from a plastic bottle
A patient with established cardiovascular disease may need multiple layers of care, including: Blood pressure management Cholesterol or ApoB management when appropriate Diabetes or prediabetes care Smoking cessation support Sleep apnea screening and treatment Nutrition and physical activity planning Medication review Cardiology follow-up Weight management Stress and sleep support GLP-1 therapy may be one tool in a larger plan
They can help rule out other conditions, such as gastroesophageal reflux disease (GERD), suggest a change to your Wegovy dosing schedule , or recommend a different treatment
Emerging technologies, such as the application of CRISPR-Cas9 technology to silence or activate specific genes in organoids, will open new doors for understanding the role of specific genes in human digestive system disease
Cellular vs fibrosing interstitial pneumonias and prognosis